Literature DB >> 32191976

[Community-acquired pneumonia in adults].

Agata Mikolajewska, Martin Witzenrath.   

Abstract

Community-acquired pneumonia (CAP) is one of the most common infectious diseases worldwide. To reduce the high morbidity and mortality of CAP, appropriate diagnosis, risk stratification and therapy are necessary. This review summarizes the current recommendations for the management of CAP in Germany. CAP is often a medical emergency. The management of a CAP is based on the individual patient risk. The DS-CRB-65 Score and ATS/IDSA major and minor criteria are well suited for risk stratification. The initially calculated antibiotic therapy is based on the expected spectrum of pathogens and should be adjusted as necessary. Antibiotic therapy is usually administered intravenously in inpatients. With oral therapy, the bioavailability of the antibiotic should be considered. A reevaluation in the first 48-72 hours is mandatory. A therapy duration of 5-7 days is usually sufficient. Preventive influenza and pneumococcal vaccination and nicotine withdrawal are important. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Year:  2020        PMID: 32191976     DOI: 10.1055/a-0993-0874

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  Two new inflammatory markers related to the CURB-65 score for disease severity in patients with community-acquired pneumonia: The hypersensitive C-reactive protein to albumin ratio and fibrinogen to albumin ratio.

Authors:  Bing Luo; Minjie Sun; Xingxing Huo; Yun Wang
Journal:  Open Life Sci       Date:  2021-01-22       Impact factor: 0.938

2.  Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study.

Authors:  Kai Liu; Weitong Zhang; Yadong Yang; Jinpeng Zhang; Yunqian Li; Ying Chen
Journal:  Complement Ther Clin Pract       Date:  2020-04-01       Impact factor: 2.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.